Romanian Society of Pharmaceutical Sciences

« Back to Farmacia Journal 4/2017

SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW N-(2-DIMETHYLAMINOETHYL)-N-((UN)SUBSTITUTED PHENYL-2-(4-METHYL/METHOXY-PHENOXYMETHYL)BENZAMIDES

HOREA GURGU 1, DIANA CAMELIA NUŢĂ 1*, MIRON TEODOR CĂPROIU 2, CONSTANTIN DRĂGHICI 2, MARIANA CARMEN CHIFIRIUC 3, ALEXANDRU VASILE MISSIR 1, CARMEN LIMBAN 1

1.Pharmaceutical Chemistry Department, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956, Bucharest, Romania
2.“Costin D. Nenițescu” The Organic Chemistry Centre of Romanian Academy, 202B Splaiul Independenței Street, 77208, Bucharest, Romania
3.Department of Botanic- Microbiology, Faculty of Biology, University of Bucharest, Research Institute of University of Bucharest - ICUB, 91-95 Splaiul Independenței Street, Bucharest, Romania

Download Full Article PDF

New N-(2-dimethylaminoethyl)-N-((un)substituted phenyl-2-(4-methyl/methoxy-phenoxymethyl)benzamide hydrochlorides were designed and synthesized from 2-(4-methyl/methoxy-phenoxymethyl)benzoyl chloride and N-(2-dimethylaminoethyl)-(un)substituted anilines, the resulted benzamides being treated with ethereal hydrochloric acid to obtain the corresponding hydrochlorides. The new compounds have been characterized by their physical constants such as melting point and solubility. The structures of the synthesized compounds were elucidated on the basis of their elemental analysis and spectroscopic data (IR, 1H-NMR and 13C-NMR). The chemical structures of all compounds and intermediaries were in full agreement with the proposed structures. The new benzamides were screened for their in vitro antimicrobial and anti-biofilm activities by quantitative assays, allowing to establish the minimum inhibitory concentration and minimal biofilm eradication concentration parameters. Compounds bearing halogenated moieties proved to be the most efficient. They showed increased activity against Gram-positive bacteria, but the activity also extends to Gram-negative bacteria and yeasts. These structures represent promising scaffolds for further development of anti-infective agents.